Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Bernice photo

Bernice R. Welles, MD, MBA

Dr. Welles has both investing experience and extensive experience building and leading development organizations, expanding company pipelines of assets, and overseeing the commercial development of innovative therapeutic products across a range of areas. Dr. Welles started her career at Genentech, where she spent nearly a decade, initially as a Clinical Scientist, then as Director and Senior Director of the Specialty Therapeutics Unit and ultimately as Vice President of Product Development. Following that she joined MPM Capital as a Venture Partner. After her time with MPM, Dr. Welles held several operating roles in San Francisco Bay Area start-ups as well as consulting for various life science companies and venture capitalists. Currently, Dr. Welles is a found partner and Managing Director with IPF Partners, an alternative financing provider focused on the healthcare sector.

Dr. Welles has a B.A. in Music from Brandeis University, an M.S. in Urban and Environmental Policy from Tufts University, an M.D. from Albany Medical College, and an M.B.A. from The Wharton School of Business, University of Pennsylvania. She has Medical Licensure, State of California, Diplomate, American Board of Internal Medicine and Diplomate, Endocrinology and Metabolism.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright West LLC. Minimum 15 minutes delayed.